MediWound (MDWD) Capital Leases (2019 - 2020)
MediWound (MDWD) posted Capital Leases of $1.9 million for Q1 2020, down 5.03% on a QoQ basis from $2.0 million in Q4 2019, and down 6.75% year-over-year from $2.0 million in Q2 2019.
Powered by 
Analysis
MediWound (MDWD) Capital Leases (2019 - 2020) Analysis & Trends
MediWound has reported Capital Leases for 2 years, with the latest figure at $1.9 million in Q1 2020.
- On a quarterly basis, Capital Leases fell 6.75% year-over-year to $1.9 million in Q1 2020; TTM through Mar 2020 was $1.9 million, a 6.75% decrease from a year earlier, with the FY2019 full-year figure at $2.0 million, changed N/A from the prior year.
- Capital Leases was $1.9 million for Q1 2020 at MediWound, down from $2.0 million in the prior quarter.
- The five-year high for Capital Leases was $2.0 million in Q1 2019, with the low at $1.9 million in Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | MediWound | 156.09 Mn | 120.75 Mn | 337,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | 1.91 Mn |
| Dec 31, 2019 | 2.01 Mn |
| Jun 30, 2019 | 2.02 Mn |
| Mar 31, 2019 | 2.04 Mn |